Signed in as:
filler@godaddy.com
DEVA Offers:
A personalised Model
DEVA supports mono- and multicellular cultures. These can include cancer cell lines, macrophages, T Cells, fibroblasts, bacteria and more.
A clinically relevant model
Our tissues maintain the ECM composition and immunosuppressive features of the TME.
A highly characterised model
We have omics data sets, IHC analysis and biophysical data from our tissues to complement the results from our assays.
A cheaper and quicker-to-use model
DEVA is run in a 96 well plate, can be set up immediately, and is cheaper to run than even simple in vivo studies
Use DEVA to determine:
Changes in immune cell phenotypes
Changes in immune cell phenotypes
Changes in immune cell phenotypes
Visit our recently published article to find out how our model reproduces immune cell phenotypes found in patients
Drug cytotoxicity
Changes in immune cell phenotypes
Changes in immune cell phenotypes
Our unique (patent-pending), non-invasive, cytotoxicity assays provide cell type specific cell killing data
ECM degradation
Real Time Cell Movement
Real Time Cell Movement
With DEVA you can quantify the therapeutic degradation of specific ECM components as well as analyse structural changes of the matrix
Real Time Cell Movement
Real Time Cell Movement
Real Time Cell Movement
Cells are not static within a tumour. With DEVA cell movement is tracked in real-time and measure the speed, direction and co-localisation of cells